stockrowAdaptive Biotechnologies Corporation
ADPT Healthcare Diagnostics & Research
Adaptive Biotechnologies Corporation’s revenue for fiscal 2025 (year ended December 2025) was $277.0 million, up 54.8% from fiscal 2024.
- Revenue
- −10.7%
- EPS
- −66.7%
- Free cash flow
- +201.9%
Quarter to September 2026, against a year earlier
Follow ADPT
Alert me
Adaptive Biotechnologies Corporation (ADPT) Book value per share
Adaptive Biotechnologies Corporation's book value per share at the end of fiscal 2025 was 1.5×, up 7.74% from 1.4× in fiscal 2024. At the end of the quarter to 30 September 2026 it was 1.1×. Over the past ten years it has ranged from 1.4× (fiscal 2024) to 27.6× (fiscal 2017); the current reading is higher than 22% of that period. Adaptive Biotechnologies Corporation ranks 33rd of 49 Diagnostics & Research companies by book value per share.
Book value per share, annual
Embed this chart
Annual newest first
| Period | Book value per share | Change |
|---|---|---|
| FY2025 | 1.5× | 7.74% |
| FY2024 | 1.4× | (35.53%) |
| FY2023 | 2.1× | (34.44%) |
| FY2022 | 3.3× | (24.34%) |
| FY2021 | 4.3× | (24.01%) |
| FY2020 | 5.7× | (31.39%) |
| FY2019 | 8.3× | (65.56%) |
| FY2018 | 24.0× | (13.17%) |
| FY2017 | 27.6× | — |
Quarterly newest first
| Period | Book value per share | Change |
|---|---|---|
| Sep 2026 | 1.1× | 21.63% |
| Jun 2026 | 0.9× | (34.63%) |
| Mar 2026 | 1.4× | (2.77%) |
| Dec 2025 | 1.5× | 10.67% |
| 31 more quarters | Free account |
Against its own ten years
Book value per share against peers
| Company | Book value per share |
|---|---|
| GRAL GRAIL, Inc. compare | 52.5× |
| RDNT RadNet, Inc. compare | 17.9× |
| VCYT Veracyte, Inc. compare | 17.8× |
| CDNA CareDx, Inc. compare | 9.0× |
| WGS GeneDx Holdings Corp. compare | 8.2× |
| NEO NeoGenomics, Inc. compare | 6.2× |
| SHC Sotera Health Company compare | 2.6× |
| ADPT Adaptive Biotechnologies Corporation | 1.1× |
| BLLN BillionToOne, Inc. compare | 0.0× |
What Book value per share is
BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.
(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))
More on ADPT
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement